Results

Total Results: 1,939 records

Showing results for "event".

241. Slide 1 (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/module_iv1.ppt
     October 31, 2011 - Done effectively, facilitation is not a one-time event that occurs while someone leads a meeting or discussion … occur during scheduled meetings Module IV Quiz: Question 2: ANSWER Facilitation is: A one-time event … dynamics and processes A superfluous skill Module IV Quiz: Question 3: Facilitation is: A one-time event

242. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-2007_executive.pdf
     January 01, 2007 - This may reflect low event rates among otherwise healthy patients and relatively few studies with extended

243. Safety of Vaccines Used for Routine Immunization in the United States (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/vaccine-safety_executive.pdf
     January 01, 2020 - Case-control studies compare people who have a disease or adverse event (“cases”) with people who do … not have the disease or event (“controls”) and look back retrospectively to compare exposure to vaccine … in each group to determine the relationship between the vaccine and the disease/ event.13,14 aLevel … SCCSs compare outcome event rates during times when a person is exposed (postvaccination) with those … Odds ratios could be calculated for each event reported in each trial and postlicensure study and,

244. Microsoft Word - finapps.doc (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_appendixes-2007.pdf
     January 01, 2007 - , blood pressure; CHF, congestive heart failure; CKD, chronic kidney disease; CVA, cerebrovascular event … treatment, or kidney function worsening (by GFR, SCr, or dialysis), or atherosclerotic cardiovascular event … unexpanded stent 0.8% Rocha- Singh 200565 208 (208) Angioplasty stent placement Major vascular event … In-hospital 2.4% Out of hospital up to 2 yr 2.9% Cerebrovascular accident 0% Major embolic event … 50% 100 Ostial: nd 3.5 yr 68% (3 yr) 59% (5 yr) C Retro 51 44% (100) 1984-2004 0-17 yr CKD event

245. DEcIDE 32: The Incident User Design in Comparative Effectiveness Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/incident-user-design_research.pdf
     May 01, 2012 - , an intervention’s benefits may require an induction period of months or years to reduce clinical event … effectiveness evidence for another reason: accurate reflections of the induction period or time-to-event … incident use of an intervention and its alternative, investigators can compare cohorts’ times until event … than older drugs because their apparent rate would be lower; investigators would observe a higher event … Studies that opt for (event) risk scores instead of propensity scores to control confounding would also

246. Disposition of Comments Report for Evidence Report 215 Safety of Vaccines Used for Routine Immunization in the United States (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/vaccine-safety_disposition-comments.pdf
     January 01, 2020 - TEP # 1 Introduction— Page 3 lines 11- 13 Change to “..the Vaccine Adverse Event Reporting System … It is also possible to have high or moderate strength of evidence for an extremely rare adverse event … Similarly, event severity was poorly described. … In many cases, the objective frequency of an event is described poorly, or not at all. … An understanding of the severity of an adverse event is necessary for decision-makers to determine

247. Disposition of Comments Report for Evidence Report 215 Safety of Vaccines Used for Routine Immunization in the United States (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/vaccine-safety_disposition-comments.pdf
     January 01, 2020 - TEP # 1 Introduction— Page 3 lines 11- 13 Change to “..the Vaccine Adverse Event Reporting System … It is also possible to have high or moderate strength of evidence for an extremely rare adverse event … Similarly, event severity was poorly described. … In many cases, the objective frequency of an event is described poorly, or not at all. … An understanding of the severity of an adverse event is necessary for decision-makers to determine

248. Clinical Effectiveness of Coronary Stents in the Elderly: Results From 262,700 Patients in the American College of Cardiology-National Cardiovascular Data Registry | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/coronary-stents-outcomes/research
     February 10, 2010 - resulted in release of two special FDA advisories in 2006, 7,8 as well as subsequent studies refining event … In the rare event that a single ACC-NCDR® record could be matched with multiple Medicare records using … Death was the only event defined both during the index PCI procedure (using ACC-NCDR® information) and … rate of repeat revascularization in our population (24%) may be due to not censoring patients after an event … Unadjusted and adjusted results from time-to-event analyses for prespecified endpoints.

249. Evidence Summary_Comparative Effectiveness Review No. 257: Schedule of Visits and Televisits for Routine Antenatal Care: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-257-antenatal-care-evidence-summary.pdf
     June 01, 2022 - supportive management, without which they expressed fears about repercussions from management in the event … of a rare adverse event associated with maternity care.

250. Microsoft Word - Comp Eff 10.doc (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-2007_research-2007-1.pdf
     January 01, 2007 - • Safety (focusing on serious adverse event rates, overall adverse event rates, and withdrawals … Key Points • Cough was modestly more frequently observed as an adverse event in groups treated with … However, the nature of serious adverse event reporting was inconsistent, and rates of serious adverse … Depending on the definition used, adverse event rates ranged from 0 to 100 percent (median 32 percent … The one adverse event for which significant differential effects were apparent is cough.

251. Recombinant-Factor-Viia Clinician (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/recombinant-factor-viia_clinician.pdf
     October 01, 2010 - In-Hospital, Off-Label Uses for rFVIIa1 Evidence on Benefits vs. Usual Care Evidence on Harms vs. Usual Care Spontaneous intracranial hemorrhage* No effect on mortality or functional status. ��� Attenuation of hematoma expansion. ��� Increased risk for arterial thromboembolic events, particularly at doses >40 …

252. The Role of Immunotherapy and the Management of Asthma: Systematic Review | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/asthma-immunotherapy/research-protocol
     September 14, 2016 - We will also review the FDA Adverse Event Reporting System (FAERS). … to judge the likelihood that the intervention was causally related to the observed serious adverse event … Summary of Protocol Amendments In the event of protocol amendments, the date of each amendment will … (McGraw Hill Concise Dictionary of Modern Medicine, 2002) An adverse event is any undesirable experience … (Food and Drug Administration, 2009) Serious adverse events (SAE): The event is serious and should

253. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/vte-protocol-8-4-10.pdf
     February 01, 2008 - observational studies which compare pharmacologic VTE prophylaxis methods will be used to report VTE event … Baseline risk of bleeding will be summarized using event rates from trials or large observational studies … KQ 3 will be addressed by qualitatively reporting event rates of both asymptomatic and symptomatic … the change scores will be calculated using the method proposed by Follman and colleagues.10 In the event … Summary of Protocol Amendments In the event of protocol amendments, the date of each amendment will

254. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/blood-clots-hip-knee-surgery_research-protocol.pdf
     February 01, 2008 - observational studies which compare pharmacologic VTE prophylaxis methods will be used to report VTE event … Baseline risk of bleeding will be summarized using event rates from trials or large observational studies … KQ 3 will be addressed by qualitatively reporting event rates of both asymptomatic and symptomatic … the change scores will be calculated using the method proposed by Follman and colleagues.10 In the event … Summary of Protocol Amendments In the event of protocol amendments, the date of each amendment will

255. RESPONSE TO REQUEST FOR WORK ASSIGNMENT (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/copd-anticholinergic-medicines_research.pdf
     December 01, 2009 - Because a medication switch may have been related to an event or an indicator of symptoms that may have … preceded this event, we did not want to attribute those events to exposure to the medications during … Specifically, an individual’s medication exposure was redefined each time there was an event during … Exposure was defined using the 180-day period prior to the day of the event. … controlling for propensity score, to examine the association between medication regimen exposure and risk of event

256. The Role of Immunotherapy and the Management of Asthma: Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-immunotherapy_research-protocol.pdf
     September 14, 2016 - We will also review the FDA Adverse Event Reporting System (FAERS). … to judge the likelihood that the intervention was causally related to the observed serious adverse event … Summary of Protocol Amendments In the event of protocol amendments, the date of each amendment will … (McGraw Hill Concise Dictionary of Modern Medicine, 2002) b) An adverse event is any undesirable experience … http://www.fda.gov/Safety/MedWatch/HowToReport/ucm053087.htm ) c) Serious adverse events (SAE): The event

257. Comparative Effectiveness of Venous Thromboembolism (VTE) Prophylaxis in Orthopedic Surgery | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/blood-clots-hip-knee-surgery/research-protocol
     August 06, 2010 - observational studies which compare pharmacologic VTE prophylaxis methods will be used to report VTE event … Baseline risk of bleeding will be summarized using event rates from trials or large observational studies … the change scores will be calculated using the method proposed by Follman and colleagues. 10 In the event … Eligibility criteria, demographics Population Events rates markedly different than in community Event … Venous thromboembolism WMD Weighted mean difference Summary of Protocol Amendments In the event

258. Rheumatoid-Arthritis-Medicine Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_executive.pdf
     April 01, 2012 - 1 Comparative Effectiveness Review Number 55 Drug Therapy for Rheumatoid Arthritis in Adults: An Update Executive Summary Background Rheumatoid arthritis (RA), which affects 1.3 million adult Americans, is an autoimmune disease that involves inflammation of the synovium (a thin layer of tissue lining a joint …

259. Acs-Pci-Adjunctive-Devices Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/acs-pci-adjunctive-devices_research-protocol.pdf
     July 01, 2010 - Eligibility criteria, demographics Population Events rates markedly different than in the community Event … Definition ACS acute coronary syndrome EPC Evidence-based Practice Center MACE major adverse cardiac event … Summary of Protocol Amendments In the event of protocol amendments, the date of each amendment will

260. Systematic Review of Calcineurin Inhibitors for Kidney Transplant | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/calcineurin-inhibitor/research-protocol
     October 14, 2014 - from the time of transplant (de novo), or later post-transplant (elective) as a result of an adverse event … undertaken at any time post-transplant and is usually a result of an unacceptable CNI related adverse event … Definition Timing Minimization Lower dosage of CNI Planned de novo, or result of adverse event … of CNI dose until eliminated and replaced with other immunosuppressant Usually result of adverse event … CNI (CNI-minimization), conversion from CNI to another immunosuppression agent following an adverse event